Viewing Study NCT00888693


Ignite Creation Date: 2025-12-25 @ 1:16 AM
Ignite Modification Date: 2025-12-25 @ 11:25 PM
Study NCT ID: NCT00888693
Status: COMPLETED
Last Update Posted: 2017-11-21
First Post: 2009-04-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Multiple Dose Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-288 in Stable Subjects With Schizophrenia
Sponsor: AbbVie
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module References Module